Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M800529-JLR200 on November 4, 2008

Papers In Press, published online ahead of print July 1, 2009
J. Lipid Res., doi:10.1194/jlr.M800529-JLR200
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M800529-JLR200v1
50/7/1384    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by James, P. F.
Right arrow Articles by Perugini, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by James, P. F.
Right arrow Articles by Perugini, M. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 50, 1384-1394, July 2009
Copyright © 2009 by American Society for Biochemistry and Molecular Biology

Aromatic residues in the C-terminal helix of human apoC-I mediate phospholipid interactions and particle morphologyboxs

Patrick F. James2,*,{dagger},§, Con Dogovski2,*,{dagger}, Renwick C. J. Dobson2,*,{dagger}, Michael F. Bailey*,{dagger}, Kenneth N. Goldie{dagger}, John A. Karas{dagger}, Denis B. Scanlon{dagger}, Richard A. J. O'Hair{dagger},§,** and Matthew A. Perugini1,*,{dagger}

* Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria 3010, Australia
{dagger} Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria 3010, Australia
§ School of Chemistry, University of Melbourne, Parkville, Victoria 3010, Australia
** ARC Center of Free Radical Chemistry and Biotechnology, University of Melbourne, Parkville, Victoria 3010, Australia
2 Patrick F. James, Con Dogovski, and Renwick C.J. Dobson contributed equally to this work.

boxs The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of two tables and five figures.

This work was supported by a scholarship from the Australian National Heart Foundation (P.F.J.); C.J. Martin Fellowship 145843 from the Australian National Health and Medical Research Council (M.F.B.); a post-doctoral fellowship and financial support from the Australian Research Council (ARC) (M.A.P.); and financial support from the ARC Centre of Excellence for Free Radical Chemistry and Biotechnology (R.A.J.O.). An ARC LIEF grant and funding from the Victorian Institute for Chemical Sciences are acknowledged for the purchase of the LTQ-FTMS (R.A.J.O.).

Published, JLR Papers in Press, November 4, 2008.

1 To whom correspondence should be addressed. e-mail: perugini{at}unimelb.edu.au

Human apolipoprotein C-I (apoC-I) is an exchangeable apolipoprotein that binds to lipoprotein particles in vivo. In this study, we employed a LC-MS/MS assay to demonstrate that residues 38–51 of apoC-I are significantly protected from proteolysis in the presence of 1,2-dimyristoyl-3-sn-glycero-phosphocholine (DMPC). This suggests that the key lipid-binding determinants of apoC-I are located in the C-terminal region, which includes F42 and F46. To test this, we generated site-directed mutants substituting F42 and F46 for glycine or alanine. In contrast to wild-type apoC-I (WT), which binds DMPC vesicles with an apparent Kd [Kd(app)] of 0.89 µM, apoC-I(F42A) and apoC-I(F46A) possess 2-fold weaker affinities for DMPC with Kd(app) of 1.52 µM and 1.58 µM, respectively. However, apoC-I(F46G), apoC-I(F42A/F46A), apoC-I(F42G), and apoC-I(F42G/F46G) bind significantly weaker to DMPC with Kd(app) of 2.24 µM, 3.07 µM, 4.24 µM, and 10.1 µM, respectively. Sedimentation velocity studies subsequently show that the protein/DMPC complexes formed by these apoC-I mutants sediment at 6.5S, 6.7S, 6.5S, and 8.0S, respectively. This is compared with 5.0S for WT apoC-I, suggesting the shape of the particles was different. Transmission electron microscopy confirmed this assertion, demonstrating that WT forms discoidal complexes with a length-to-width ratio of 2.57, compared with 1.92, 2.01, 2.16, and 1.75 for apoC-I(F42G), apoC-I(F46G), apoC-I(F42A/F46A), and apoC-I(F42G/F46G), respectively. Our study demonstrates that the C-terminal amphipathic {alpha}-helix of human apoC-I contains the major lipid-binding determinants, including important aromatic residues F42 and F46, which we show play a critical role in stabilizing the structure of apoC-I, mediating phospholipid interactions, and promoting discoidal particle morphology.

Supplementary key words analytical ultracentrifugation • apo • C1 • CI • electron microscopy • lipid metabolism • lipidomics • mass spectrometry • phospholipid • protein-lipid interaction

Abbreviations: apoC-I, apolipoprotein C-I; CD, circular dichroism; CETP, cholesterol ester transfer protein; CID, collision induced dissociation; DMPC, 1,2-dimyristoyl-3-sn-glycero-phosphocholine; EM, electron microscopy; ESI, electrospray ionization; FT, Fourier transform; IDL, intermediate density lipoprotein; IT, ion trap; LB, Luria-Bertani; LC, liquid chromatography; LUV, large unilamellar vesicle; MBP, maltose binding protein; MS, mass spectrometry; MS/MS, tandem mass spectrometry; rmsd, root mean square deviation; SUV, small unilamellar vesicle; TAE, Tris-acetate-EDTA buffer


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement